- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: A population-based study - Abstract
November 30, 2012
Lapatinib and renal cell carcinoma - Abstract
November 30, 2012
Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma - Abstract
November 30, 2012
Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents - Abstract
November 30, 2012
Renal tumors and second primary pancreatic tumors: A relationship with clinical impact? - Abstract
November 30, 2012
A case-control study of occupation/industry and renal cell carcinoma risk - Abstract
November 30, 2012
Multiple metastatic renal cell carcinoma isolated to pancreas - Abstract
November 29, 2012
Integrating innovative therapeutic strategies into the management of renal cell carcinoma - Abstract
November 29, 2012
Active surveillance for renal cell carcinoma - Abstract
November 29, 2012
State-of-the-art management of renal cell carcinoma - Abstract
November 28, 2012
Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma - Abstract
November 28, 2012
Temsirolimus: A safety and efficacy review - Abstract
November 26, 2012
Safety and tolerability of pazopanib in the treatment of renal cell carcinoma - Abstract
November 26, 2012
Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy - Abstract
November 26, 2012
Kidney injury during VEGF inhibitor therapy - Abstract
November 23, 2012
Pseudoaneurysm after laparoscopic partial nephrectomy for an 11-cm renal tumor - Abstract
November 23, 2012